Description
Recombinant monoclonal antibody to CCR2. Manufactured using AbAbТs Recombinant Platform with variable regions (i.e. specificity) from the synthetic antibody MLN1202 (Plozalizumab, hu1D9). This is a reformatted mouse IgG2b Fc SilentЩ antibody, based on the original mouse IgG1 format, created for improved compatibility with existing reagents, assays and techniques.
Target
CCR2
Target Alias Names
CD192, C-C chemokine receptor type 2, C-C CKR-2, CC-CKR-2, CCR-2, Monocyte chemoattractant protein 1 receptor, MCP-1-R, CMKBR2, MLN-1202, 4.9.2, LS132.1D9
Isotype/Mimetic
IgG2b
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-free discovery, Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression